Breast Cancer Research

official impact factor 5.79

This article is part of the supplement: 24th Congress of the International Association for Breast Cancer Research. Advances in human breast cancer research: preclinical models

Transgenic models are predictive: the herceptin and flavopiridol experience

E Schmidt

  • Correspondence: E Schmidt

Breast Cancer Res 2003, 5(Suppl 1):28 doi:10.1186/bcr687

Accesses  

  • Last 30 days: 2 accesses
  • Last 365 days: 69 accesses
  • All time: 553 accesses